首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins
【24h】

Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins

机译:犬遥测研究中的自动化血液取样:使心血管负债和安全利润的增强评估

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: A successful integration of automated blood sampling (ABS) into the telemetry instrumented canine cardiovascular model is presented in this study. This combined model provides an efficient means to quickly gain understanding of potential effects on key cardiovascular parameters in dog while providing a complete Pharmacokinetic/Pharmacodynamic (PK/PD) profile for discovery compounds without handling artifacts, reducing the need for a separate pharmacokinetic study. Methods: Male beagle dogs were chronically implanted with telemetry devices (PhysioTelTM model D70-PCTP) and vascular access ports (SPMID-GRIDAC-5NC). BASi Culex-L automated blood sampling (Bioanalytical Systems, Inc) system was used to collect blood samples at multiple time points. A series of four use cases utilizing four different test compounds and analytical endpoints are described to illustrate some of the potential applications of the technique. Results: In the four presented use cases, automated blood sampling in telemetry instrumented dogs provides simultaneous cardiovascular (heart rate, arterial blood pressure, and left ventricular pressure), electrophysiological assessment (QTc, PR, and QRS intervals), body temperature, and animal activity, while collecting multiple blood samples for drug analysis. Conclusion: The combination of automated blood sampling with cardiovascular telemetry monitoring is a novel capability designed to support safety pharmacology cardiovascular assessment of discovery molecules. By combining telemetry and high-fidelity ABS, the model provides an enhanced PK/PD understanding of druginduced hemodynamic and electrocardiographic effects of discovery compounds in conscious beagles in the same experimental session. Importantly, the model can reduce the need for a separate pharmacokinetic study (positive reduction 3R impact), reduces compound syntheses requirements, and shorten development timelines. Furthermore, implementation of this approach has also improved animal welfare by reducing the animal handling during a study, thereby reducing stress and associated data artifacts (positive refinement 3R impact).
机译:导言:本研究成功地将自动血液采样(ABS)集成到遥测仪器化犬心血管模型中。这种组合模型提供了一种有效的方法,可以快速了解对狗关键心血管参数的潜在影响,同时在不处理伪影的情况下为发现化合物提供完整的药代动力学/药效学(PK/PD)曲线,从而减少单独药代动力学研究的需要。方法:雄性比格犬长期植入遥测设备(PhysioTelTM D70-PCTP型)和血管通路端口(SPMID-GRIDAC-5NC)。BASi Culex-L自动血液采样(生物分析系统公司)系统用于在多个时间点采集血液样本。本文描述了一系列使用四种不同测试化合物和分析终点的四个用例,以说明该技术的一些潜在应用。结果:在上述四个使用案例中,遥测仪器狗的自动血液采样可同时提供心血管(心率、动脉血压和左心室压力)、电生理评估(QTc、PR和QRS间期)、体温和动物活动,同时采集多个血液样本进行药物分析。结论:自动血液采样与心血管遥测监测相结合是一种新的功能,旨在支持发现分子的安全药理学心血管评估。通过结合遥测和高保真ABS,该模型增强了PK/PD对药物诱导的血流动力学和发现化合物在清醒比格犬体内的心电图效应的理解。重要的是,该模型可以减少单独药代动力学研究的需要(积极减少3R影响),减少化合物合成需求,缩短开发时间。此外,该方法的实施还通过减少研究过程中的动物处理来改善动物福利,从而减少压力和相关数据伪影(积极的3R影响)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号